Researchers find protein that may stop autoimmune diseases and allergies
Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...
Atara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219
Atara Biotherapeutics (ATRA) announced that the FDA has placed a clinical hold on Atara’s active investigational new drug, or IND, ...
lupus.bmj18h
Ultrasonographic assessment of optic nerve: does it help in lupus-induced optic neuropathy?
Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in ...
lupusnewstoday1d
Discovering 2 lupus prayers I didn’t know I needed for the new year
It takes courage to be our genuine selves, writes columnist Candace Semien, who shares a couple powerful prayers for lupus.
emjreviews.com4d
Nearly 20% of Patients With Lupus Face Added Burden of Fibromyalgia
Study reveals fibromyalgia impacts nearly 20% of lupus patients, reducing quality of life and calling for improved diagnosis ...
CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year
CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...
lupusnewstoday5d
Caribou Phase 1 trial testing safety, efficacy of CAR T-cell therapy
Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...
Targeted Oncology6d
Academic Perspectives for LR-MDS Treatment in the Community
Panelists discuss key learnings from recent studies on lower-risk myelodysplastic syndrome (LR-MDS) treatment, identify ...